| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0205 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2001-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01a191700ae0bd1cec98a894cc14e43c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499cbe465601a4f5dbddd73df3273c07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b1c3fb65c3c2b4f4d3d06a7a1688084 |
| publicationDate |
2002-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002111338-A1 |
| titleOfInvention |
Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| abstract |
This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed to pharmaceutical compositions including and methods using such compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11402395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11525835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8828665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005028268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10203345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11231424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009041806-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9970929-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005226927-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9861115-B2 |
| priorityDate |
2000-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |